phase readout
saveNCT03485677: Safety and Efficacy of Eliglustat With or Without Imiglucerase in Pediatric Patients With Gaucher Disease (GD) Type 1 and Type 3
COMPLETEDupdated 11d ago
community read0 votes
Sponsor: Sanofi. Phase: PHASE3. Conditions: Gaucher's Disease Type I, Gaucher's Disease Type III
view source ↗
comments(0)
5-min edit window · permanent after that